Explore

Trendline Trendline
Savara Inc. to Present at BioConnect Investor Conference

Savara Inc. to Present at BioConnect Investor Conference

Savara Inc. to Present at BioConnect Investor Conference
Trendline Trendline
DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Trendline Trendline
Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus

Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus

Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus
Trendline Trendline
AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform
Trendline Trendline
Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
Trendline Trendline
Halia Therapeutics to Present Phase 2 Ofirnoflast Data and Appoints New Chief Medical Officer

Halia Therapeutics to Present Phase 2 Ofirnoflast Data and Appoints New Chief Medical Officer

Halia Therapeutics to Present Phase 2 Ofirnoflast Data and Appoints New Chief Medical Officer
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
Alto Neuroscience to Participate in Major Investor Conferences

Alto Neuroscience to Participate in Major Investor Conferences

Alto Neuroscience to Participate in Major Investor Conferences